Youxin KONG, Senior Scientist and Alexey RAK, Scientific fellow, head of department, Vitry-Sur-Seine, France

Youxin KONG, Senior Scientist and Alexey RAK, Scientific fellow, head of department, Vitry-Sur-Seine, France

First quarter 2025

First quarter 2025 results were reviewed by management during a live audio webcast with the financial community.


Our Latest Stories

Your Health

April 11, 2025

More to the Story of CIDP: a Complex Neuromuscular Condition

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

About Us

Who We Are

We are an innovative global healthcare company.

Our Pipeline

5

Therapeutic areas

86

Compounds in clinical development

24

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases


April 25, 2025
Media Update: Sanofi’s Foundation S and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program

April 24, 2025
Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed

April 18, 2025
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

April 15, 2025
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD